Topics

German court grants injunction after ruling that Sanofi, Regeneron's Praluent infringes patent on Amgen's Repatha http://www.firstwordpharma.com/node/1652637  $SNY $REGN $AMGN

06:13 EDT 12 Jul 2019 | FirstWord Pharma

German court grants injunction after ruling that Sanofi, Regeneron's Praluent infringes patent on Amgen's Repatha http://www.firstwordpharma.com/node/1652637 

Original Article: German court grants injunction after ruling that Sanofi, Regeneron's Praluent infringes patent on Amgen's Repatha http://www.firstwordpharma.com/node/1652637  $SNY $REGN $AMGN

NEXT ARTICLE

More From BioPortfolio on "German court grants injunction after ruling that Sanofi, Regeneron's Praluent infringes patent on Amgen's Repatha http://www.firstwordpharma.com/node/1652637  $SNY $REGN $AMGN"

Quick Search

Relevant Topics

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...